Tamiflu takers: Watch out for bizarre behavior
Strange side effects reported overseas spur FDA to review labeling
Updated: 2:55 p.m. CT Nov 13, 2006
Doctors and parents should watch for signs of bizarre behavior in children treated with the flu drug Tamiflu, federal health officials suggested Monday in citing an increasing number of such cases from overseas.
Food and Drug Administration officials still don’t know if the more than 100 new cases, including three deaths from falls, are linked to the drug or to the flu virus — or a combination of both. Most of the reported cases involved children.
Still, FDA staff suggested updating Tamiflu’s label to recommend that all patients, especially children, be closely monitored while on the drug. They also acknowledged that stopping treatment with Tamiflu could actually harm influenza patients if the virus is the cause of delirium, hallucinations and other abnormal behavior, such as aggression and suicidal thoughts.
http://www.msnbc.msn.com/id/15701254/Roche's Tamiflu to Add Warning on Psychiatric Risks (Update1)
By Catherine Larkin
Nov. 13 (Bloomberg) -- Roche Holding AG's Tamiflu flu treatment must carry information warning of potential risks of psychiatric side effects, U.S. regulators said.
The Food and Drug Administration approved a labeling revision to include information on those risks after reports of self-injury and mutilation among Japanese patients using the drug, the agency said today in an e-mailed statement. Most of these side effects were reported in children.
http://www.bloomberg.com/apps/news?pid=20601087&sid=aLUqmToDWYS8&refer=home